{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:34:09Z","timestamp":1790393649029,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1124\/dmd.112.045021","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T05:23:56Z","timestamp":1331011436000},"page":"1067-1075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Immune-Mediated Agranulocytosis Caused by the Cocaine Adulterant Levamisole: A Case for Reactive Metabolite(s) Involvement"],"prefix":"10.1016","volume":"40","author":[{"given":"Angela","family":"Wolford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Eng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Hansel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit S.","family":"Kalgutkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.045021_bib1","first-page":"137","article-title":"Pharmacokinetics of levamisole","volume":"4","author":"Adams","year":"1978","journal-title":"J Rheumatol Suppl"},{"key":"10.1124\/dmd.112.045021_bib2","first-page":"343","article-title":"Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar","volume":"81","author":"Albonico","year":"2003","journal-title":"Bull World Health Organ"},{"key":"10.1124\/dmd.112.045021_bib3","first-page":"150","article-title":"Captopril-associated agranulocytosis","volume":"1","author":"Amann","year":"1980","journal-title":"Lancet"},{"key":"10.1124\/dmd.112.045021_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0192-0561(83)90065-6","article-title":"The dosage regimen of levamisole in cancer: is it related to efficacy and safety?","volume":"5","author":"Amery","year":"1983","journal-title":"Int J Immunopharmacol"},{"key":"10.1124\/dmd.112.045021_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0192-0561(92)90179-O","article-title":"Levamisole, the story and the lessons","volume":"14","author":"Amery","year":"1992","journal-title":"Int J Immunopharmacol"},{"key":"10.1124\/dmd.112.045021_bib6","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jpba.2011.03.039","article-title":"Determination of aminorex in human urine samples by GC-MS after use of levamisole","volume":"55","author":"Bertol","year":"2011","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.112.045021_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-010611-134701","article-title":"Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex","volume":"52","author":"Bharadwaj","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.112.045021_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0041-008X(87)90314-0","article-title":"The hematological effects of cefonicid and cefazedone in the dog: a potential model of cephalosporin hematotoxicity in man","volume":"90","author":"Bloom","year":"1987","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.112.045021_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s13181-010-0060-3","article-title":"A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole","volume":"6","author":"Buchanan","year":"2010","journal-title":"J Med Toxicol"},{"key":"10.1124\/dmd.112.045021_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13181-010-0097-3","article-title":"Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole","volume":"7","author":"Buchanan","year":"2011","journal-title":"J Med Toxicol"},{"key":"10.1124\/dmd.112.045021_bib11","first-page":"82","article-title":"Identification of levamisole impurities found in illicit cocaine exhibits","volume":"6","author":"Casale","year":"2008","journal-title":"DEA Resources, Microgram Journal"},{"key":"10.1124\/dmd.112.045021_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/clpt.2010.156","article-title":"Levamisole: a dangerous new cocaine adulterant","volume":"88","author":"Chang","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.112.045021_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-98-1-26","article-title":"Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose","volume":"98","author":"Cooper","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1124\/dmd.112.045021_bib14","first-page":"177","article-title":"Levamisole in the treatment of cancer: anything new? (Review)","volume":"12","author":"De Brabander","year":"1992","journal-title":"Anticancer Res"},{"key":"10.1124\/dmd.112.045021_bib15","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/cncr.24969","article-title":"Cyclophosphamide, methotrexate, and fluorouracil; oral cyclophosphamide; levamisole; or no adjuvant therapy for patients with high-risk, premenopausal breast cancer","volume":"116","author":"Ejlertsen","year":"2010","journal-title":"Cancer"},{"key":"10.1124\/dmd.112.045021_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(75)91305-7","article-title":"Letter: neutropenia associated with metiamide","volume":"1","author":"Forrest","year":"1975","journal-title":"Lancet"},{"key":"10.1124\/dmd.112.045021_bib17","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1378\/chest.118.5.1496","article-title":"Recreational use of aminorex and pulmonary hypertension","volume":"118","author":"Gaine","year":"2000","journal-title":"Chest"},{"key":"10.1124\/dmd.112.045021_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-3-642-81685-7_57","article-title":"Biologic-response modifiers and adjuvant chemotherapy: consideration of selected preclinical investigations in relation to clinical potential","volume":"80","author":"Goldin","year":"1982","journal-title":"Recent Results Cancer Res"},{"key":"10.1124\/dmd.112.045021_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/07357909109032808","article-title":"Levamisole and the new era of chemoimmunotherapy","volume":"9","author":"Greenspan","year":"1991","journal-title":"Cancer Invest"},{"key":"10.1124\/dmd.112.045021_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0300-483X(93)90066-2","article-title":"Myeloperoxidase-mediated activation of xenobiotics by human leukocytes","volume":"82","author":"Hofstra","year":"1993","journal-title":"Toxicology"},{"key":"10.1124\/dmd.112.045021_bib21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000232788","article-title":"Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies","volume":"65","author":"Hodinka","year":"1981","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1124\/dmd.112.045021_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00128072-200305050-00006","article-title":"The management of idiopathic nephrotic syndrome in children","volume":"5","author":"Hodson","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1124\/dmd.112.045021_bib23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.165.8.869","article-title":"Population-based drug-induced agranulocytosis","volume":"165","author":"Ib\u00e1\u00f1ez","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1124\/dmd.112.045021_bib24","first-page":"347","article-title":"The levamisole story","volume":"20","author":"Janssen","year":"1976","journal-title":"Prog Drug Res"},{"key":"10.1124\/dmd.112.045021_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/art.1780230205","article-title":"The toxicity pattern of D-penicillamine therapy. A guide to its use in rheumatoid arthritis","volume":"23","author":"Kean","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1124\/dmd.112.045021_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/bdd.2510070110","article-title":"Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine","volume":"7","author":"Kouassi","year":"1986","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.112.045021_bib27","first-page":"869","article-title":"Metabolic fate of levamisole in rats, dogs and monkeys","volume":"26","author":"Koyama","year":"1983","journal-title":"Pharmacometrics (Tokyo)"},{"key":"10.1124\/dmd.112.045021_bib28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-3565(24)35100-6","article-title":"Metabolism of trimethoprim to a reactive iminoquinone methide by activated human neutrophils and hepatic microsomes","volume":"291","author":"Lai","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.045021_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-5347(24)06172-X","article-title":"Oxidation and binding of [2-14C]-propylthiouracil in human polymorphonuclear leukocytes","volume":"7","author":"Lam","year":"1979","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045021_bib30","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/0006-2952(90)90428-N","article-title":"Mechanism of inactivation of myeloperoxidase by propylthiouracil","volume":"39","author":"Lee","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.045021_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/taap.1998.8582","article-title":"Atypical antipsychotic-induced neutropenia in dogs","volume":"155","author":"Lorenz","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.112.045021_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/bmj.1.6110.407","article-title":"Levamisole-induced vasculitis due to circulating immune complexes","volume":"1","author":"Macfarlane","year":"1978","journal-title":"Br Med J"},{"key":"10.1124\/dmd.112.045021_bib33","first-page":"77","article-title":"A study of the hematological side effects of levamisole in rheumatoid arthritis with recommendations","volume":"4","author":"Mielants","year":"1978","journal-title":"J Rheumatol Suppl"},{"key":"10.1124\/dmd.112.045021_bib34","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3109\/03602538409041080","article-title":"Captopril: pharmacology, metabolism and disposition","volume":"15","author":"Migdalof","year":"1984","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.112.045021_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.7326\/0003-4819-122-5-199503010-00001","article-title":"Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report","volume":"122","author":"Moertel","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1124\/dmd.112.045021_bib36","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(77)92386-8","article-title":"Complications of cancer immunotherapy with levamisole","volume":"1","author":"Parkinson","year":"1977","journal-title":"Lancet"},{"key":"10.1124\/dmd.112.045021_bib37","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1034\/j.1398-9995.2002.02161.x","article-title":"Pathogenesis of drug-induced exanthems","volume":"57","author":"Pichler","year":"2002","journal-title":"Allergy"},{"key":"10.1124\/dmd.112.045021_bib38","first-page":"399","article-title":"Captopril-associated agranulocytosis. A report of 3 cases","volume":"79","author":"Pillans","year":"1991","journal-title":"S Afr Med J"},{"key":"10.1124\/dmd.112.045021_bib39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.pa.28.040188.002055","article-title":"The immunologic and metabolic basis of drug hypersensitivities","volume":"28","author":"Pohl","year":"1988","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.112.045021_bib40","series-title":"WHO Food Additives Series 33: Toxicological evaluation of certain veterinary drug residues in food","first-page":"805","article-title":"Levamisole","author":"Roberts","year":"1994"},{"key":"10.1124\/dmd.112.045021_bib41","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1046\/j.1365-2133.1999.02833.x","article-title":"Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children","volume":"140","author":"Rongioletti","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1124\/dmd.112.045021_bib42","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3109\/00498259109039562","article-title":"Hydrogen peroxide-dependent oxidation metabolism of 1-methyl-2-mercaptoimidazole (methimazole) catalysed by myeloperoxidase","volume":"21","author":"Sayo","year":"1991","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.112.045021_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0192-0561(81)90040-0","article-title":"Levamisole\u2013a general pharmacological perspective","volume":"3","author":"Schnieden","year":"1981","journal-title":"Int J Immunopharmacol"},{"key":"10.1124\/dmd.112.045021_bib44","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3109\/00498259109039513","article-title":"Metabolism of levamisole, an anti-colon cancer drug, by human intestinal bacteria","volume":"21","author":"Shu","year":"1991","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.112.045021_bib45","first-page":"1721","article-title":"Adverse reactions to levamisole","volume":"62","author":"Symoens","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"10.1124\/dmd.112.045021_bib46","series-title":"Pharmacological and Biochemical Properties of Drug Substances. Vol. 2","author":"Symoens","year":"1979"},{"key":"10.1124\/dmd.112.045021_bib47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1021\/tx00009a011","article-title":"Metabolic activation of eugenol by myeloperoxidase and polymorphonuclear leukocytes","volume":"2","author":"Thompson","year":"1989","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.112.045021_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/RHU.0b013e31820e6822","article-title":"Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine","volume":"17","author":"Ullrich","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1124\/dmd.112.045021_bib49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/03602539208996297","article-title":"The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions","volume":"24","author":"Uetrecht","year":"1992","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.112.045021_bib50","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1001\/archinte.1985.00360120143044","article-title":"D-penicillamine and neutrophilic agranulocytosis","volume":"145","author":"Umeki","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1124\/dmd.112.045021_bib51","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0090-9556(25)07126-0","article-title":"Oxidation of propylthiouracil to reactive metabolites by activated neutrophils. Implications for agranulocytosis","volume":"19","author":"Waldhauser","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.045021_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2006.02.036","article-title":"From discovery to development: current industry perspectives for the development of novel methods of helminth control in livestock","volume":"139","author":"Waller","year":"2006","journal-title":"Vet Parasitol"},{"key":"10.1124\/dmd.112.045021_bib53","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaad.2010.01.055","article-title":"Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit?","volume":"63","author":"Waller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1124\/dmd.112.045021_bib54","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1600-0560.2010.01613.x","article-title":"Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole","volume":"37","author":"Walsh","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1124\/dmd.112.045021_bib55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0034-5288(18)30975-5","article-title":"Levamisole pharmacokinetics and bioavailability in dogs","volume":"45","author":"Watson","year":"1988","journal-title":"Res Vet Sci"},{"key":"10.1124\/dmd.112.045021_bib56","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archderm.1980.01640320052013","article-title":"The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation","volume":"116","author":"Wilkin","year":"1980","journal-title":"Arch Dermatology"},{"key":"10.1124\/dmd.112.045021_bib57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-4347(00)80134-6","article-title":"Determination of levamisole in plasma and animal tissues by gas chromatography with thermionic specific detection","volume":"224","author":"Woestenborghs","year":"1981","journal-title":"J Chromatogr"},{"key":"10.1124\/dmd.112.045021_bib58","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1016\/0006-2952(83)90313-1","article-title":"Drug protein conjugates\u2013VI. Role of glutathione in the metabolism of captopril and captopril plasma protein conjugates","volume":"32","author":"Yeung","year":"1983","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.045021_bib59","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0091-3057(92)90462-O","article-title":"Aminorex produces stimulus effects similar to amphetamine and unlike those of fenfluramine","volume":"42","author":"Young","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/dmd.112.045021_bib60","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7326\/0003-4819-150-4-200902170-00102","article-title":"Agranulocytosis after consumption of cocaine adulterated with levamisole","volume":"150","author":"Zhu","year":"2009","journal-title":"Ann Intern Med"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562422691X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562422691X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.045021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T20:08:16Z","timestamp":1739909296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562422691X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S009095562422691X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.045021","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-Mediated Agranulocytosis Caused by the Cocaine Adulterant Levamisole: A Case for Reactive Metabolite(s) Involvement","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.045021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}